N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
CAS: 183321-74-6
Ref. TR-E625008
| 1g | 140.00 € | ||
| 25g | 658.00 € | ||
| 500mg | 91.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Product Information
Name:
N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
Controlled Product
Synonyms:
- Erlotinib
- 4-Quinazolinamine
- N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
- 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline
- NSC 718781
- OSI 744
- R 1415
- 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
- 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline
- Erlotinib & its intermediates (Developing)
- See more synonyms
- Erlotinib Base
- Erlotinin
- N-(3-Ethynylphenyl)[6,7-Bis(2-Methoxyethoxy)Quinazolin-4-Yl]Amine
- Osi 744
Description:
Applications Erlotinib is a EGFR-targeted drug in the treatment of non-small cell lung cancer. EGFR small tyrosine kinase inhibitor that shows most substantial effect on tumor growth inhibition and animal survival.
References Zhu, B., et al.: Xiandai Zhenduan Yu Zhiliao, 25, 4679 (2014); Yao, T., et al.: Ther. Targets Neurol. Dis., 2, 585 (2015)
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
393.44
Formula:
C22H23N3O4
Color/Form:
Neat
InChI:
InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
SMILES:
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-E625008 N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
